HemaSphere
HemaSphere is an online-only fully open-access journal of the European Hematology Association, published by Wiley since January 2024 and founded by the Association in 2017, and its 2025 Journal Impact Factor of 11.3 places it in the first quartile of Hematology该刊(《HemaSphere》)是(European Hematology Association)旗下的血液学刊,仅在线出版、完全开放获取,2024 年 1 月起改由(Wiley)出版,由该学会于 2017 年创办,2025 年影响因子为 11.3,在血液学学科居 Q1 区。
Scope
- Its stated aim is to publish the results of highly relevant basic, translational and clinical research in hematology, with a preference for strong studies reporting novel findings of high impact to the field其宗旨是发表血液学高度相关的基础、转化与临床研究结果,尤重为该领域带来重大影响的新发现的高质量研究。
- Review articles, guideline articles and controversy articles give clear overviews and discussions of new developments together with recommendations for patient care综述、指南与争议三类文章为新进展提供清晰梳理与讨论,并给出患者诊疗建议。
- Original articles, reviews, guideline articles, controversies and letters have formed the body of text since the first year, when seven issues carried 28 articles and 13 letters原创研究、综述、指南、争议与读者来信自创刊首年即构成正文主体,当年 7 期刊出 28 篇文章与 13 封来信。[1]
- Bibliographic registries classify the journal under diseases of the blood and blood-forming organs, with the MeSH headings Hematologic Diseases and Hematology and English as its language书目登记系统把该刊归入血液与造血器官疾病类,主题词为(Hematologic Diseases)与(Hematology),出版语言为英语。
- Because it is electronic only, a single online identifier, eISSN 2572-9241, serves every role and each article receives an electronic article number instead of print pagination因纯粹电子版出版,单一在线标识 2572-9241 承担全部角色,每篇文章以电子文号而非纸质页码编排。
- The journal also documents the meetings of European hematology, since congress abstract books of the Association appear in dedicated supplements该刊同时记录欧洲血液学的学术会议,学会年会摘要汇编以专刊形式发表。[2]
History
- The European Hematology Association created the title as its own scientific journal and the first issue appeared in December 2017(European Hematology Association)为学会自有科学期刊而创办该刊,2017 年 12 月出版首期。
- EHA set out four cornerstones at launch: an editorial team of field experts, a focus on high-quality work, low publication costs and full open access学会创办时定下四项支点,即由本领域专家组成编辑团队、专注高质量研究、出版费低廉、完全开放获取。
- Haematologica, owned by the Ferrata Storti Foundation, had long served as the scientific journal of the Association, and from 2019 onward this journal became the only one affiliated to it(Haematologica)由(Ferrata Storti Foundation)主办,长期担任该学会的科学期刊;自 2019 年起该刊成为其唯一关联期刊。[1]
- Its founding editorial leadership was a pair of co-Editors-in-Chief, Jan Cools of the VIB-KU Leuven Center for Cancer Biology and Andreas Engert of the University Hospital of Cologne, who were still signing joint editorials in 2021其创刊编辑班子由两位联合主编构成,即(VIB-KU Leuven Center for Cancer Biology)的 Jan Cools 与(University Hospital of Cologne)的 Andreas Engert,二人到 2021 年仍联名发表社论。[3]
- Wolters Kluwer Health published the journal on behalf of the Association for its first volumes, and from January 2024 Wiley took over, which also moved article identifiers from the 10.1097 HS9 prefix to the 10.1002 hem3 prefix前几卷由(Wolters Kluwer Health)代表该学会出版,2024 年 1 月起改由(Wiley)接手,文章数字对象标识也随之由 10.1097 前缀换成 10.1002 前缀。
- Its issue count grew from the bimonthly rhythm of the earliest volumes to twelve issues a year, and its Journal Impact Factor ran 8.3 for 2022 and 14.6 for 2024 before settling at 11.3 for 2025刊期由最早几卷的双月刊节奏增至每年 12 期,影响因子依次为 2022 年 8.3、2024 年 14.6、2025 年 11.3。
Editors
- The Editorial Board listed by the Association is led by Editor-in-Chief Jan Cools of the VIB-KU Leuven Center for Cancer Biology in Belgium, whose field is cancer biology and leukemia genetics学会所列编委会由主编 Jan Cools 负责,他任职于比利时(VIB-KU Leuven Center for Cancer Biology),研究领域为癌症生物学与白血病遗传学。
- Claire Harrison of the United Kingdom is Deputy Editor-in-Chief and already held that post while the journal was with Wolters Kluwer来自英国的 Claire Harrison 任副主编,在该刊隶属(Wolters Kluwer)时期她已担任此职。
- The declared composition is one Editor-in-Chief, one Deputy Editor-in-Chief, up to fifteen Associate Editors and up to six Scientific Editors编委会的既定构成为主编 1 人、副主编 1 人、副编辑至多 15 人、科学编辑至多 6 人。
- The Associate Editors on the current roster come from the Netherlands, Italy, the United Kingdom, Germany, the Czech Republic, Spain, Switzerland and the United States and include Jeroen Eikenboom, Marek Mraz, Steffen Koschmieder and Paula Rodriguez Otero现任副编辑来自荷兰、意大利、英国、德国、捷克、西班牙、瑞士与美国,其中包括 Jeroen Eikenboom、Marek Mraz、Steffen Koschmieder 与 Paula Rodriguez Otero。
- Scientific Editors are drawn from an even wider geography that reaches Australia and Ghana, and a dedicated Statistics Editor from the United Kingdom carries out statistical review科学编辑的地域覆盖更广,远及澳大利亚与加纳,另设来自英国的统计编辑负责统计学审阅。
- There is no submission charge, the declared peer-review model is double anonymous, and accepted articles are released as gold open access under Creative Commons terms against an article processing charge of 2880 US dollars该刊不收投稿费,声明的评审方式为双匿名同行评审,录用稿件以金色开放获取方式按知识共享条款发布,文章处理费为 2880 美元。
References
- ^Engert A, Cools J. The first year of HemaSphere and many more to come. HemaSphere, 2018, 2(6):e161. doi:10.1097/HS9.0000000000000161
- ^EHA2021 Virtual Congress Abstract Book. HemaSphere, 2021, 5:e566. doi:10.1097/HS9.0000000000000566
- ^Cools J, Engert A. The fifth year of HemaSphere. HemaSphere, 2021, 5(6):e588. doi:10.1097/HS9.0000000000000588